Sorafenib in the management of metastatic renal cell carcinoma

PURPOSE: Sorafenib represents one of the two standards of care for patients with metastatic renal cell carcinoma (mrcc). In the present review, we provide information regarding the use of sorafenib in first and second lines. We also describe results for dose escalation strategies. Finally, we provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Guevremont, C., Jeldres, C., Perrotte, P., Karakiewicz, P.I.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2009
Materias:
Urologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687798/
https://www.ncbi.nlm.nih.gov/pubmed/19478894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687798/
https://www.ncbi.nlm.nih.gov/pubmed/19478894

Ejemplares similares